4//SEC Filing
SANGAMO BIOSCIENCES INC 4
Accession 0001140361-15-027954
$SGMOCIK 0001001233operating
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:49 PM ET
Size
10.3 KB
Accession
0001140361-15-027954
Insider Transaction Report
Form 4
LANPHIER EDWARD O II
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-07-15−25,000→ 25,000 totalExercise: $6.82Exp: 2016-12-12→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2015-07-15$6.82/sh+25,000$170,500→ 260,000 total - Sale
Common Stock
2015-07-15$10.43/sh−25,000$260,770→ 235,000 total
Holdings
- 1,185,521(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Includes 60,000, 50,000 shares and 125,000 subject to RSUs granted on December 6, 2012, December 12, 2013 and December 11, 2014, respectively, that will be issued as such units vest in accordance with their terms.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2014.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.98, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]These shares are held in the Edward O. Lanphier II and Cameron M. Lanphier Trust U/T/A August 30, 2002, Edward O. Lanphier II and Cameron M. Lanphier, Trustees.
- [F5]All shares underlying these options are vested and exercisable immediately, and such options will expire on December 12, 2016.
Documents
Issuer
SANGAMO BIOSCIENCES INC
CIK 0001001233
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001001233
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:49 PM ET
- Size
- 10.3 KB